Cleared Traditional

K970255 - KIPP MED I.V. MANIFOLD

K970255 is an FDA 510(k) clearance for KIPP MED I.V. MANIFOLD, manufactured by The Kipp Group. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 82-day FDA review.

K970255 · The Kipp Group · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1997
Decision
82d
Days
Class 2
Risk

K970255 is an FDA 510(k) clearance for the KIPP MED I.V. MANIFOLD. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by The Kipp Group (Ontario, US). The FDA issued a Cleared decision on April 14, 1997 after a review of 82 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all The Kipp Group devices

FDA 510(k) Submission Details - K970255

510(k) Number K970255 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 22, 1997
Decision Date April 14, 1997
Days to Decision 82 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 129d · This submission: 82d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 644
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K970255.
SAFE-CONNECT I.V. EXTENSION SET
K970524 · Faulding Medical Device Co. · Apr 1997
SMARTSITE ACCESS PIN
K970485 · Ivac Medical Systems · Apr 1997
NIMA NEEDLELESS INJECTIONSITE MASTER ADAPTER WITH POSIFLOW POSITIVE DISPLACEMENT FEATURE, AND I.V. SETS
K964918 · Critical Device Corp. · Apr 1997
E-Z SET INFUSION SET/SAF-T E-Z SET INFUSION SET
K970259 · Becton Dickinson Vascular Access, Inc. · Apr 1997
INTERLINK MICRO-INFUSION MANIFOLD EXTENSION SETS
K970438 · Baxter Healthcare Corp · Apr 1997
MAXCESS NEEDLEFREE - Y- SITE (100713)
K970800 · Solopak Medical Products, Inc. · Apr 1997